Home LiteratureArticle Details
PMID: 6912277 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.

The Journal of experimental medicine ·Vol. 154 ·No. 3 ·1981-09-01 ·Pages 856-67

Pangburn MK, Schreiber RD, Müller-Eberhard HJ

Abstract

Activation of the alternative pathway of complement commences with the formation of an initial fluid-phase C3 convertase. Treatment of C3 with the nucleophilic reagent methylamine has previously been shown to result in the cleavage of an intramolecular thioester bond and to induce C3b-like properties, including the ability to form a fluid-phase C3 convertase. This report examines the hypothesis that spontaneous hydrolysis of the thioester generates a derivative of C3 that is responsible for the formation of the initial C3 convertase of the alternative pathway. The rate of spontaneous decay of C3 hemolytic activity in buffer was found to be between 0.2 and 0.4%/h. In the presence of other alternative pathway proteins, the rate of inactivation was 1%/h. The rate of spontaneous inactivation was greatly accelerated by low concentrations of chaotrophic agents such as KSCN or guanidine. Liberation of a sulfhydryl group, not present in native C3, correlated with loss of hemolytic activity, indicating that exposure to chaotropic agents resulted in thioester hydrolysis. Unlike native C3, C3 bearing a single reactive sulfhydryl group was capable of generating fluid-phase C3 convertase with Factors B, D, and P and was cleaved by Factor I (C3b inactivator) in the presence of Factor H (beta 1H). The fragmentation patterns indicated that the C3a domain was covalently associated with the functionally C3b-like C3. Organomercurial agarose was employed for the rapid removal of sulfhydryl-bearing, hemolytically inactive forms of C3 and C3b from native hemolytically active C3.

MeSH Terms
Complement Activating Enzymes/metabolism Complement Activation Complement C3/metabolism Complement C3-C5 Convertases/metabolism Complement C3b/biosynthesis Complement Pathway, Alternative Hemolysis Hydrolysis Indicators and Reagents Protein Denaturation Sulfhydryl Compounds/metabolism
Chemicals
Complement C3 Indicators and Reagents Sulfhydryl Compounds Complement C3b Complement Activating Enzymes Complement C3-C5 Convertases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Pangburn M K
Schreiber R D
Müller-Eberhard H J
References (25)
25 references, click to expand
  1. Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.
    J Immunol. 1966 Nov;97(5):680-5 PMID: 5926456
  2. The reaction mechanism of human C5 in immune hemolysis.
    J Exp Med. 1970 Oct 1;132(4):775-93 PMID: 5508377
  3. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
    Immunology. 1973 Feb;24(2):259-75 PMID: 4632688
  4. Initiation of C3 cleavage in the alternative complement pathway.
    J Immunol. 1975 Nov;115(5):1357-61 PMID: 809512
  5. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    J Exp Med. 1975 Sep 1;142(3):760-72 PMID: 1165475
  6. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
    J Biol Chem. 1975 Nov 10;250(21):8293-301 PMID: 1238393
  7. Third component of human complement: purification from plasma and physicochemical characterization.
    Biochemistry. 1976 Oct 5;15(20):4513-21 PMID: 823964
  8. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
    J Immunol. 1977 Feb;118(2):525-32 PMID: 839069
  9. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    J Exp Med. 1977 Jul 1;146(1):257-70 PMID: 301546
  10. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):3948-52 PMID: 279011
  11. Mechanism of action of factor D of the alternative complement pathway.
    J Exp Med. 1978 Dec 1;148(6):1498-509 PMID: 82604
  12. Characterization of alkylamine-sensitive site in alpha 2-macroglobulin.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4313-6 PMID: 92026
  13. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.
    Biochemistry. 1980 Sep 16;19(19):4471-8 PMID: 7407085
  14. Third component of human complement: structural requirements for its function.
    Biochemistry. 1980 Sep 16;19(19):4479-85 PMID: 7407086
  15. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    J Exp Med. 1980 Oct 1;152(4):1102-14 PMID: 6903192
  16. Effect of methylamine on the structure and function of the fourth component of human complement, C4.
    J Biol Chem. 1980 Nov 10;255(21):10025-8 PMID: 7430113
  17. Evidence for presence of an internal thiolester bond in third component of human complement.
    Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764-8 PMID: 6934510
  18. Covalent binding and hemolytic activity of complement proteins.
    Proc Natl Acad Sci U S A. 1980 Dec;77(12):7194-8 PMID: 6938964
  19. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
    Biochemistry. 1981 Jul 21;20(15):4458-67 PMID: 7284336
  20. The covalent-binding reaction of complement component C3.
    Biochem J. 1981 Jan 1;193(1):115-27 PMID: 7305916
  21. The separation of functionally distinct forms of the third component of human complement (C3).
    Biochem J. 1981 Mar 1;193(3):963-70 PMID: 6458280
  22. Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b.
    Scand J Immunol. 1981;13(5):413-31 PMID: 6171865
  23. Tissue sulfhydryl groups.
    Arch Biochem Biophys. 1959 May;82(1):70-7 PMID: 13650640
  24. Isolation and characterization of two beta1-glycoproteins of human serum.
    J Exp Med. 1960 Feb 1;111:201-15 PMID: 13726744
  25. Isolation and description of proteins related to the human complement system.
    Acta Soc Med Ups. 1961;66:152-70 PMID: 14477150
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1981-09-01
Pages
856-67
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2186450
Subset
IM
Grants
NIAID NIH HHS · AI-07007 · United States
NIAID NIH HHS · AI-13010 · United States
NHLBI NIH HHS · HL-1641 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]